Main container

Analisi multi-omica integrata per predire l’evoluzione delle gammopatie monoclonali

Title
Analisi multi-omica integrata per predire l’evoluzione delle gammopatie monoclonali
Code
PNRR-2022-12376660
Type
Sperimentale
Start Year
2023
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
20/04/2023 14:48